Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs AZO✓SelectedUSD · AZOGSK vs AZO performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs AZO

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+41.1%
AZO return
+75.0%
Excess return
-33.9%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioAZOExcessAlpha
1D-0.1%-0.7%+0.5%0.0%
7D-5.3%-0.1%-5.2%-5.3%
30D-3.7%+3.1%-6.8%-4.3%
3M-7.3%+9.9%-17.2%-9.2%
6M-4.2%-4.8%+0.6%-3.7%
YTD+0.9%-4.0%+4.9%+1.0%
1Y+7.3%-15.4%+22.7%+10.1%
3Y+52.7%+22.9%+29.9%+45.5%
All+41.1%+75.0%-33.9%+22.9%

Cumulative growth

Daily Returns

Daily percentage return beside AZO.

Daily Out/Under-Performance

Portfolio return minus AZO return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × AZO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded AZO wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling